SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-23-000041
Filing Date
2023-05-12
Accepted
2023-05-11 19:53:15
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20230331.htm   iXBRL 10-Q 1025146
2 EX-10.5 a105_230511xamendmenttoexe.htm EX-10.5 16083
3 EX-31.1 skye-20230331xex311.htm EX-31.1 10591
4 EX-31.2 skye-20230331xex312.htm EX-31.2 11120
5 EX-32.1 skye-20230331xex321.htm EX-32.1 5172
6 EX-32.2 skye-20230331xex322.htm EX-32.2 5312
  Complete submission text file 0001516551-23-000041.txt   5981219

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20230331.xsd EX-101.SCH 58068
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20230331_cal.xml EX-101.CAL 58426
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20230331_def.xml EX-101.DEF 286900
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20230331_lab.xml EX-101.LAB 623002
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20230331_pre.xml EX-101.PRE 398887
62 EXTRACTED XBRL INSTANCE DOCUMENT skye-20230331_htm.xml XML 802241
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 23912761
SIC: 2834 Pharmaceutical Preparations